Published in Dev Neurobiol on April 01, 2010
Brain on stress: how the social environment gets under the skin. Proc Natl Acad Sci U S A (2012) 2.77
Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev (2012) 2.54
Social influences on neuroplasticity: stress and interventions to promote well-being. Nat Neurosci (2012) 2.49
Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science (2011) 2.25
Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J Clin Invest (2011) 2.25
Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology (2011) 1.98
Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex. Neuropsychopharmacology (2015) 1.97
Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci (2012) 1.90
The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry (2010) 1.80
Mechanisms of stress in the brain. Nat Neurosci (2015) 1.47
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology (2011) 1.44
Overview of the genetics of major depressive disorder. Curr Psychiatry Rep (2010) 1.39
Opioid receptors: distinct roles in mood disorders. Trends Neurosci (2012) 1.31
Understanding resilience. Front Behav Neurosci (2013) 1.19
The ever-changing brain: cellular and molecular mechanisms for the effects of stressful experiences. Dev Neurobiol (2012) 1.15
Human biomarkers of rapid antidepressant effects. Biol Psychiatry (2013) 1.09
Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-like behavior in female mice. Biol Psychiatry (2012) 1.05
Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII. Neuropsychopharmacology (2012) 1.04
Sustained expression of brain-derived neurotrophic factor is required for maintenance of dendritic spines and normal behavior. Neuroscience (2012) 1.04
Toward a biosignature for suicide. Am J Psychiatry (2014) 1.03
Recognizing Resilience: Learning from the Effects of Stress on the Brain. Neurobiol Stress (2015) 1.03
Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol (2013) 1.02
The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy. Mol Psychiatry (2015) 1.02
A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philos Trans R Soc Lond B Biol Sci (2012) 1.02
'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression. Philos Trans R Soc Lond B Biol Sci (2013) 1.01
Serum brain-derived neurotrophic factor levels in different neurological diseases. Biomed Res Int (2013) 1.01
The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophr Bull (2015) 0.99
Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test. Ups J Med Sci (2012) 0.99
Epigenetic Modulation of Mood Disorders. J Genet Syndr Gene Ther (2013) 0.98
DNA methylation and childhood maltreatment: from animal models to human studies. Neuroscience (2013) 0.98
Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration. Mol Psychiatry (2011) 0.97
Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation. Front Cell Neurosci (2015) 0.97
Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. J Neuroinflammation (2011) 0.96
Epigenetics and psychiatry. Neurotherapeutics (2013) 0.96
Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Curr Neuropharmacol (2011) 0.96
Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders. J Neural Transm (Vienna) (2010) 0.95
HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand? Biochem Soc Trans (2014) 0.95
The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus. Neural Plast (2013) 0.94
Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a spatial code for BDNF splice variants. Neuropsychopharmacology (2012) 0.94
Effects of diabetes on hippocampal neurogenesis: links to cognition and depression. Neurosci Biobehav Rev (2013) 0.93
Hippocampal volume and total cell numbers in major depressive disorder. J Psychiatr Res (2012) 0.93
Neuroplasticity and the next wave of antidepressant strategies. Front Cell Neurosci (2013) 0.92
Are BDNF and glucocorticoid activities calibrated? Neuroscience (2012) 0.92
Resilience and vulnerability: a neurobiological perspective. F1000Prime Rep (2013) 0.92
Transcranial direct current stimulation for memory enhancement: from clinical research to animal models. Front Syst Neurosci (2014) 0.91
The neuronal insulin sensitizer dicholine succinate reduces stress-induced depressive traits and memory deficit: possible role of insulin-like growth factor 2. BMC Neurosci (2012) 0.91
The age-by-disease interaction hypothesis of late-life depression. Am J Geriatr Psychiatry (2013) 0.91
Management of patients with stroke: is it time to expand treatment options? Ann Neurol (2013) 0.91
The interesting interplay between interneurons and adult hippocampal neurogenesis. Mol Neurobiol (2011) 0.90
Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment. Neuropsychopharmacology (2012) 0.90
Cochlear implants matching the prosthesis to the brain and facilitating desired plastic changes in brain function. Prog Brain Res (2011) 0.89
The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig (2010) 0.89
Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatment. PLoS One (2011) 0.89
Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide. J Neuroinflammation (2011) 0.89
Novel control by the CA3 region of the hippocampus on neurogenesis in the dentate gyrus of the adult rat. PLoS One (2011) 0.88
Long-term effects of maternal immune activation on depression-like behavior in the mouse. Transl Psychiatry (2014) 0.88
BDNF-ERK-CREB signalling mediates the role of miR-132 in the regulation of the effects of oleanolic acid in male mice. J Psychiatry Neurosci (2014) 0.87
Nobiletin Ameliorates the Deficits in Hippocampal BDNF, TrkB, and Synapsin I Induced by Chronic Unpredictable Mild Stress. Evid Based Complement Alternat Med (2013) 0.87
In a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis. Behav Pharmacol (2010) 0.86
Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats. Cell Mol Neurobiol (2012) 0.86
Enhanced antidepressant-like effects of electroacupuncture combined with citalopram in a rat model of depression. Evid Based Complement Alternat Med (2013) 0.86
Neurotrophin and Wnt signaling cooperatively regulate dendritic spine formation. Mol Cell Neurosci (2013) 0.86
Synergistic effects of celecoxib and bupropion in a model of chronic inflammation-related depression in mice. PLoS One (2013) 0.86
Lurasidone for the treatment of bipolar depression: an evidence-based review. Neuropsychiatr Dis Treat (2015) 0.85
Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC. Psychopharmacology (Berl) (2011) 0.85
Impact of aerobic exercise on neurobehavioral outcomes. Ment Health Phys Act (2013) 0.85
Fluoxetine prevents development of an early stress-related molecular signature in the rat infralimbic medial prefrontal cortex. Implications for depression? BMC Neurosci (2012) 0.85
Treadmill exercise alleviates stress-induced impairment of social interaction through 5-hydroxytryptamine 1A receptor activation in rats. J Exerc Rehabil (2015) 0.85
Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesis. BMC Neurosci (2012) 0.85
7-Chlorokynurenic acid (7-CTKA) produces rapid antidepressant-like effects: through regulating hippocampal microRNA expressions involved in TrkB-ERK/Akt signaling pathways in mice exposed to chronic unpredictable mild stress. Psychopharmacology (Berl) (2014) 0.85
Neurotrophic-priming of glucocorticoid receptor signaling is essential for neuronal plasticity to stress and antidepressant treatment. Proc Natl Acad Sci U S A (2015) 0.84
Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants. J Exp Biol (2015) 0.83
The responsiveness of TrkB to BDNF and antidepressant drugs is differentially regulated during mouse development. PLoS One (2012) 0.83
From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF). Pharmaceutics (2013) 0.83
Multistage drug effects of ketamine in the treatment of major depression. Eur Arch Psychiatry Clin Neurosci (2014) 0.82
Common Polymorphisms in the Age of Research Domain Criteria (RDoC): Integration and Translation. Biol Psychiatry (2015) 0.82
Postsynaptic TRPC1 function contributes to BDNF-induced synaptic potentiation at the developing neuromuscular junction. J Neurosci (2011) 0.82
Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers. Drug Alcohol Depend (2014) 0.82
COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study. Neuropsychiatr Dis Treat (2014) 0.82
Nimodipine activates TrkB neurotrophin receptors and induces neuroplastic and neuroprotective signaling events in the mouse hippocampus and prefrontal cortex. Cell Mol Neurobiol (2014) 0.82
Ceruloplasmin deficiency results in an anxiety phenotype involving deficits in hippocampal iron, serotonin, and BDNF. J Neurochem (2011) 0.81
Controversies about a common etiology for eating and mood disorders. Front Psychol (2014) 0.81
New targets for rapid antidepressant action. Prog Neurobiol (2015) 0.81
β-Alanine supplemented diets enhance behavioral resilience to stress exposure in an animal model of PTSD. Amino Acids (2015) 0.81
Gene expression patterns underlying the reinstatement of plasticity in the adult visual system. Neural Plast (2013) 0.81
Huntingtin-associated protein 1 regulates postnatal neurogenesis and neurotrophin receptor sorting. J Clin Invest (2013) 0.81
Association of decreased serum brain-derived neurotrophic factor (BDNF) concentrations in early pregnancy with antepartum depression. BMC Psychiatry (2015) 0.81
Increased frequency of first-episode poststroke depression after discontinuation of escitalopram. Stroke (2011) 0.81
GDNF and BDNF gene interplay in chronic tinnitus. Int J Mol Epidemiol Genet (2012) 0.81
Age-dependent role for Ras-GRF1 in the late stages of adult neurogenesis in the dentate gyrus. Hippocampus (2014) 0.80
Linking Mitochondria to Synapses: New Insights for Stress-Related Neuropsychiatric Disorders. Neural Plast (2016) 0.80
Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial. Clin Psychopharmacol Neurosci (2014) 0.80
The interplay of stress and sleep impacts BDNF level. PLoS One (2013) 0.80
Effects of fluoxetine on memory under forced treadmill exercise conditions in male rats. Adv Biomed Res (2015) 0.79
Fluoxetine increases the expression of NCAM140 and pCREB in rat C6 glioma cells. Psychiatry Investig (2012) 0.79
Effects of amitriptyline and fluoxetine on synaptic plasticity in the dentate gyrus of hippocampal formation in rats. Adv Biomed Res (2014) 0.79
MicroRNA regulation of central glial cell line-derived neurotrophic factor (GDNF) signalling in depression. Transl Psychiatry (2015) 0.79
Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment. PLoS One (2013) 0.78
WY14643 produces anti-depressant-like effects in mice via the BDNF signaling pathway. Psychopharmacology (Berl) (2014) 0.78
SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway. Int J Neuropsychopharmacol (2014) 0.78
Role of neurotrophic factors in depression. Curr Opin Pharmacol (2006) 2.39
Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines. Cell Mol Neurobiol (2005) 1.08
Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro. Mol Biol Cell (2008) 1.01
Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice. Neurobiol Aging (2011) 1.01
BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse. Neurobiol Dis (2010) 1.00
Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment. CNS Drugs (2010) 0.95
Neurotrophins in depression and antidepressant effects. Novartis Found Symp (2008) 0.95
The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice. Neuropharmacology (2011) 0.94
Brain-derived neurotrophic factor controls activity-dependent maturation of CA1 synapses by downregulating tonic activation of presynaptic kainate receptors. J Neurosci (2009) 0.87
Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus. Neuropharmacology (2011) 0.86
Alterations in BDNF and phospho-CREB levels following chronic oral nicotine treatment and its withdrawal in dopaminergic brain areas of mice. Neurosci Lett (2011) 0.83
The responsiveness of TrkB to BDNF and antidepressant drugs is differentially regulated during mouse development. PLoS One (2012) 0.83
Darkness reduces BDNF expression in the visual cortex and induces repressive chromatin remodeling at the BDNF gene in both hippocampus and visual cortex. Cell Mol Neurobiol (2010) 0.83
Effects of maternal smoking and exposure to methylmercury on brain-derived neurotrophic factor concentrations in umbilical cord serum. Toxicol Sci (2010) 0.83
Nimodipine activates TrkB neurotrophin receptors and induces neuroplastic and neuroprotective signaling events in the mouse hippocampus and prefrontal cortex. Cell Mol Neurobiol (2014) 0.82
Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo. Cell Mol Neurobiol (2009) 0.81
Brief Isoflurane Anesthesia Produces Prominent Phosphoproteomic Changes in the Adult Mouse Hippocampus. ACS Chem Neurosci (2016) 0.81